New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - verapamil hydrochloride 240mg - modified release tablet - 240 mg - active: verapamil hydrochloride 240mg excipient: l-green lake zlt 601 glycol montanate hypromellose macrogol 400 macrogol 6000 magnesium stearate microcrystalline cellulose povidone purified talc purified water sodium alginate titanium dioxide - · angina pectoris - for the prophylaxis and treatment of coronary insufficiency: chronic stable angina pectoris; angina at rest including vasospastic (prinzmetal's, variant angina) and unstable angina (crescendo, pre-infarction angina); angina pectoris post myocardial infarction.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - trandolapril, quantity: 4 mg; verapamil hydrochloride, quantity: 240 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; povidone; hypromellose; sodium stearylfumarate; microcrystalline cellulose; sodium alginate; magnesium stearate; hyprolose; macrogol 400; macrogol 6000; purified talc; colloidal anhydrous silica; titanium dioxide; iron oxide red; iron oxide yellow; iron oxide black; docusate sodium - tarka is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - trandolapril, quantity: 2 mg; verapamil hydrochloride, quantity: 180 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; povidone; hypromellose; sodium stearylfumarate; microcrystalline cellulose; sodium alginate; magnesium stearate; hyprolose; macrogol 400; macrogol 6000; purified talc; colloidal anhydrous silica; titanium dioxide; iron oxide red; iron oxide yellow; iron oxide black; docusate sodium - tarka is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - anpec is indicated for:,-hypertension,-angina of effort,-angina at rest,-vasospastic angina (including prinzmetal?s variant angina),-tachyarrhythmias including paroxysmal supra-ventricular tachycardia,-atrial fibrillation with rapid ventricular response,-atrial flutter with rapid ventricular response

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ireland limited - verapamil hydrochloride - film-coated tablets - 80mg - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - prophylaxis and/or treatment of:-
angina pectoris, including prinzmetal’s angina (coronary spasm, vasospastic angina).
supraventricular tachycardias such as paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with rapid ventricular response (except in wpw syndrome, see “contraindications”).
mild to moderate essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - verapamil hydrochloride - film-coated tablet - 120 milligram(s) - phenylalkylamine derivatives; verapamil - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - prophylaxis and/or treatment of:-
angina pectoris, including prinzmetal’s angina (coronary spasm, vasospastic angina).
supraventricular tachycardias such as paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with rapid ventricular response (except in wpw syndrome, see “contraindications”).
mild to moderate essential hypertension

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - verapamil hydrochloride - film-coated tablet - 40 milligram(s) - phenylalkylamine derivatives; verapamil - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - prophylaxis and/or treatment of: angina pectoris, including prinzmetal’s angina (coronary spasm, vasospastic angina):; supraventricular tachycardias such as paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with rapid ventricular response (except in wpw syndrome, see “contra-indications”); mild to moderate essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - verapamil hydrochloride - film-coated tablet - 80 milligram(s) - phenylalkylamine derivatives; verapamil

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

abbott laboratories s.a. (pty) ltd - tablet - 80,0 mg - each tablet contains verapamil 80,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

abbott laboratories s.a. (pty) ltd - tablet - 120,0 mg - each tablet contains verapamil 120 mg